Home

walk Observatory Western mirna marker of tace rfa gossip No way Sui

Cancers | Free Full-Text | Locoregional Therapy Approaches for  Hepatocellular Carcinoma: Recent Advances and Management Strategies
Cancers | Free Full-Text | Locoregional Therapy Approaches for Hepatocellular Carcinoma: Recent Advances and Management Strategies

Frontiers | Non-coding RNAs in hepatocellular carcinoma: Insights into  regulatory mechanisms, clinical significance, and therapeutic potential
Frontiers | Non-coding RNAs in hepatocellular carcinoma: Insights into regulatory mechanisms, clinical significance, and therapeutic potential

Cancer stem cells in hepatocellular carcinoma — from origin to clinical  implications | Nature Reviews Gastroenterology & Hepatology
Cancer stem cells in hepatocellular carcinoma — from origin to clinical implications | Nature Reviews Gastroenterology & Hepatology

Cancers | Free Full-Text | Current State of Liver-Directed Therapies and  Combinatory Approaches with Systemic Therapy in Hepatocellular Carcinoma  (HCC)
Cancers | Free Full-Text | Current State of Liver-Directed Therapies and Combinatory Approaches with Systemic Therapy in Hepatocellular Carcinoma (HCC)

Cancers | Free Full-Text | The Incidence of Bacteremia and Risk Factors of  Post-Radiofrequency Ablation Fever for Patients with Hepato-Cellular  Carcinoma
Cancers | Free Full-Text | The Incidence of Bacteremia and Risk Factors of Post-Radiofrequency Ablation Fever for Patients with Hepato-Cellular Carcinoma

Biomedicines | Free Full-Text | Circulating MicroRNA-21 and MicroRNA-122 as  Prognostic Biomarkers in Hepatocellular Carcinoma Patients Treated with  Transarterial Chemoembolization
Biomedicines | Free Full-Text | Circulating MicroRNA-21 and MicroRNA-122 as Prognostic Biomarkers in Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization

Serum exosomal microRNA‑122 and microRNA‑21 as predictive biomarkers in  transarterial chemoembolization‑treated hepatocellular carcinoma patients
Serum exosomal microRNA‑122 and microRNA‑21 as predictive biomarkers in transarterial chemoembolization‑treated hepatocellular carcinoma patients

PDF) MicroRNAs Related to TACE Treatment Response: A Review of the  Literature from a Radiological Point of View
PDF) MicroRNAs Related to TACE Treatment Response: A Review of the Literature from a Radiological Point of View

Frontiers | Clinical Applications of Liquid Biopsy in Hepatocellular  Carcinoma
Frontiers | Clinical Applications of Liquid Biopsy in Hepatocellular Carcinoma

JPM | Free Full-Text | Transarterial Chemoembolization for Hepatocellular  Carcinoma: Why, When, How?
JPM | Free Full-Text | Transarterial Chemoembolization for Hepatocellular Carcinoma: Why, When, How?

MiR-4492 predicts therapy response to trans-arterial chemoembolization... |  Download Scientific Diagram
MiR-4492 predicts therapy response to trans-arterial chemoembolization... | Download Scientific Diagram

The Diagnostic and Prognostic Potential of MicroRNAs for Hepatocellular  Carcinoma | IntechOpen
The Diagnostic and Prognostic Potential of MicroRNAs for Hepatocellular Carcinoma | IntechOpen

Plasma MicroRNA-21, 26a, and 29a-3p as Predictive Markers for Treatment  Response Following Transarterial Chemoembolization in Pa
Plasma MicroRNA-21, 26a, and 29a-3p as Predictive Markers for Treatment Response Following Transarterial Chemoembolization in Pa

Cancers | Free Full-Text | Clinical Usefulness of Surgical Resection  Including the Complementary Use of Radiofrequency Ablation for  Intermediate-Stage Hepatocellular Carcinoma
Cancers | Free Full-Text | Clinical Usefulness of Surgical Resection Including the Complementary Use of Radiofrequency Ablation for Intermediate-Stage Hepatocellular Carcinoma

Pathophysiology of recurrent hepatocellular carcinoma after radiofrequency  ablation - Ikemoto - 2017 - Hepatology Research - Wiley Online Library
Pathophysiology of recurrent hepatocellular carcinoma after radiofrequency ablation - Ikemoto - 2017 - Hepatology Research - Wiley Online Library

Cancers | Free Full-Text | Surgical Resection plus Intraoperative Radiofrequency  Ablation versus Chemoembolization for the Treatment of Intermediate-Stage  (BCLC B) Hepatocellular Carcinoma with Preserved Liver Function: A  Propensity Score-Matched Analysis
Cancers | Free Full-Text | Surgical Resection plus Intraoperative Radiofrequency Ablation versus Chemoembolization for the Treatment of Intermediate-Stage (BCLC B) Hepatocellular Carcinoma with Preserved Liver Function: A Propensity Score-Matched Analysis

Treatment algorithm for hepatocellular carcinoma (HCC). RFA,... | Download  Scientific Diagram
Treatment algorithm for hepatocellular carcinoma (HCC). RFA,... | Download Scientific Diagram

Barcelona Clinic Liver Cancer Staging System and treatment allocation.... |  Download Scientific Diagram
Barcelona Clinic Liver Cancer Staging System and treatment allocation.... | Download Scientific Diagram

JPM | Free Full-Text | Transarterial Chemoembolization for Hepatocellular  Carcinoma: Why, When, How?
JPM | Free Full-Text | Transarterial Chemoembolization for Hepatocellular Carcinoma: Why, When, How?

Recent perspectives on therapeutic significance of microRNAs in  hepatocellular carcinoma - ScienceDirect
Recent perspectives on therapeutic significance of microRNAs in hepatocellular carcinoma - ScienceDirect

Novel miRNA signature for predicting the stage of hepatocellular carcinoma  | Scientific Reports
Novel miRNA signature for predicting the stage of hepatocellular carcinoma | Scientific Reports

Targeted therapy for hepatocellular carcinoma | Signal Transduction and  Targeted Therapy
Targeted therapy for hepatocellular carcinoma | Signal Transduction and Targeted Therapy

Recent perspectives on therapeutic significance of microRNAs in  hepatocellular carcinoma - ScienceDirect
Recent perspectives on therapeutic significance of microRNAs in hepatocellular carcinoma - ScienceDirect

Serum exosomal microRNA‑122 and microRNA‑21 as predictive biomarkers in  transarterial chemoembolization‑treated hepatocellular carcinoma patients
Serum exosomal microRNA‑122 and microRNA‑21 as predictive biomarkers in transarterial chemoembolization‑treated hepatocellular carcinoma patients

PDF) The clinical significance of microRNA-122 in predicting the prognosis  of patients with hepatocellular carcinoma: A meta-analysis validated by the  Cancer Genome Atlas dataset
PDF) The clinical significance of microRNA-122 in predicting the prognosis of patients with hepatocellular carcinoma: A meta-analysis validated by the Cancer Genome Atlas dataset

Hepatocellular carcinoma and microRNA: New perspectives on therapeutics and  diagnostics - ScienceDirect
Hepatocellular carcinoma and microRNA: New perspectives on therapeutics and diagnostics - ScienceDirect

Circulating tumor DNAs and non-coding RNAs as potential biomarkers for  hepatocellular carcinoma diagnosis, prognosis and response to therapy
Circulating tumor DNAs and non-coding RNAs as potential biomarkers for hepatocellular carcinoma diagnosis, prognosis and response to therapy

Circulating tumor cells as a prognostic biomarker in patients with  hepatocellular carcinoma | Scientific Reports
Circulating tumor cells as a prognostic biomarker in patients with hepatocellular carcinoma | Scientific Reports

Pathophysiology of recurrent hepatocellular carcinoma after radiofrequency  ablation - Ikemoto - 2017 - Hepatology Research - Wiley Online Library
Pathophysiology of recurrent hepatocellular carcinoma after radiofrequency ablation - Ikemoto - 2017 - Hepatology Research - Wiley Online Library